Laparoscopic insufflator is a surgical
device used during a laparoscopic surgery to insufflate gases into the
peritoneal cavity to produce pneumoperitoneum. During the laparoscopic
surgery, the abdomen is usually insufflated with carbon dioxide gas to
elevate the abdominal walls from the vital organs in the abdominal
cavity to create working and viewing space. Other gases such as air,
oxygen, nitrous oxide (N2O), helium, argon, and mixture of these gases
are also used to create the pneumoperitoneum. The choice of the gas
depends on several factors such as type of anesthesia, toxicity,
non-combustibility, safety, compatibility, and ease of use. Currently,
carbon dioxide is the most frequently used gas as it is non-flammable,
colorless, non-explosive, and is available at lower cost than other
gases. The CO2 gas is usually insufflated into the abdominal cavity at
the rate of 4-6 liter/minute at 10-20 mm Hg pressure. The laparoscopic
insufflators are characterized by the gas insufflation flow rate, smoke
evacuation features, gas heating, and safety features such as visual and
sound alarms. These insufflators facilitate the increased operating
space and clarity of vision during laparoscopic surgeries.
The global laparoscopic insufflators
market is projected to be driven by factors such as increasing
popularity and acceptance of minimally invasive surgeries for most of
the abdominal surgical procedures as compared to open surgical
procedures. The minimally invasive surgery, also known as laparoscopic
surgery or keyhole surgery, is widely used by most of the surgeons
worldwide for various abdominal surgical procedures due to lesser pain,
shorter hospital stays, and low cost. The wide application of
laparoscopic surgeries for bowel resection, hernia repair,
fundoplication, nephrectomy, cholecystectomy, and gynecological
procedure is likely to fuel the market growth in the near future.
Furthermore, there has been an increasing adoption of laparoscopic
surgeries in emergency operations, which is anticipated to drive the
market for laparoscopic insufflators during the forecast period.
Technological advancement in instruments such as smoke evacuation, gas
filters, and maintenance of flow pressures is likely to boost the demand
for updated insufflators. However, stringent regulatory guidelines on
medical devices in countries such as the U.S. and the U.K. pose
difficulty for the registration and approval of the newer laparoscopic
insufflators.
The global laparoscopic insufflators
market is broadly segmented on the basis of product type, end-user, and
geography. In terms of product type, the market is categorized into two
sub segments; laparoscopy insufflator with smoke evacuation and
laparoscopy insufflator without smoke evacuation. The smoke evacuation
feature automatically evacuates the smoke from abdomen generated during
surgery and provides a clear view. The end-users of laparoscopic
insufflators include hospitals and ambulatory surgical centers. The
hospitals segment is projected to account for a significant market share
by 2025. However, the ambulatory surgical centers segment is expected
to expand at a high CAGR during the forecast period.
Geographically, the global laparoscopic
insufflators market is segmented into five regions: North America,
Europe, Asia Pacific, Latin America, and Middle East & Africa. North
America and Europe are projected to dominate the global market by 2025.
Large market share and global dominance of these regions are attributed
to well-established health care infrastructure, high per capita health
care expenditure, and rapid increase and adoption of minimally invasive
surgery for various abdominal diseases. Asia Pacific is anticipated to
witness a high growth rate during the forecast period owing to rapidly
improving health care facilities and infrastructure, and increased
investment by leading international hospital chains in emerging
countries such as China, India, South Korea, and Malaysia. In addition,
increasing preference for minimally invasive surgeries over conventional
open surgeries is likely to propel the growth of the Asia Pacific
market during the forecast period.
Key companies operating in the global
laparoscopic insufflators market include Conmed Corporation, B. Braun
Melsungen AG, Ecleris S.R.L., Olympus Corporation, Maxerendoscopy,
Stryker Corporation, Hospiinz International, COMEG, US Endoscopy (STERIS
Corporation), and Smith & Nephew Plc. These companies are striving
to develop laparoscopic insufflators with smoke evacuator feature to
facilitate clear vision during surgeries.
No comments:
Post a Comment